Correction to: Neurofilament Light Chain is a Biomarker of Neurodegeneration in Ataxia Telangiectasia

Affiliations

¹ Division of Allergology, Pulmonology and Cystic Fibrosis, Department for Children and Adolescents, Goethe University, Frankfurt, Germany. Helena.Donath@kgu.de.
² Division of Allergology, Pulmonology and Cystic Fibrosis, Department for Children and Adolescents, Goethe University, Frankfurt, Germany.
³ Division of Pediatric Neurology, Department for Children and Adolescents, Goethe University, Frankfurt, Germany.
⁴ Experimental Neurology, Medical School, Goethe University, Frankfurt, Germany.

Published Erratum

H Donath et al. Cerebellum. 2022 Feb.

. 2022 Feb;21(1):48.

doi: 10.1007/s12311-021-01280-5.

¹ Division of Allergology, Pulmonology and Cystic Fibrosis, Department for Children and Adolescents, Goethe University, Frankfurt, Germany. Helena.Donath@kgu.de.
² Division of Allergology, Pulmonology and Cystic Fibrosis, Department for Children and Adolescents, Goethe University, Frankfurt, Germany.
³ Division of Pediatric Neurology, Department for Children and Adolescents, Goethe University, Frankfurt, Germany.
⁴ Experimental Neurology, Medical School, Goethe University, Frankfurt, Germany.

No abstract available

Erratum for

Neurofilament Light Chain Is a Biomarker of Neurodegeneration in Ataxia Telangiectasia.
Donath H, Woelke S, Schubert R, Kieslich M, Theis M, Auburger G, Duecker RP, Zielen S. Donath H, et al. Cerebellum. 2022 Feb;21(1):39-47. doi: 10.1007/s12311-021-01257-4. Epub 2021 Apr 24. Cerebellum. 2022. PMID: 33893614 Free PMC article. Clinical Trial.